FloodLAMP Surveillance FAQ and Links (June 2022 DRAFT) The surveillance vs. diagnostic testing explainer contrasts patient-focused diagnostic testing (clinical care and individual results under the medical/CLIA framework) with population-focused surveillance testing used to monitor and mitigate spread without reporting patient-specific results. It summarizes federal agency roles and quotes CMS and FDA guidance indicating surveillance testing can occur outside CLIA and outside FDA authorization when individual results are not returned, while individual asymptomatic screening with reported results remains regulated. primary file regulatory surveillance FloodLAMP Surveillance FAQ and Links (June 2022 DRAFT).md regulatory/surveillance/FloodLAMP Surveillance FAQ and Links (June 2022 DRAFT).md 2022_06_01 edited text to remove redundant quoted sections and links and instead link to other FL archive file gdoc docx CC BY 4.0 - https://creativecommons.org/licenses/by/4.0/ 200 292 gfile-url xfile-github-download-url pdf-gdrive-url pdf-github-url github-markdown-url github-markdown-download-url web-pdf-url web-slides-url youtube-url web-url